Chidozie Anyaegbu

Mr, Dr

  • The University of Western Australia (M507), 35 Stirling Highway,

    6009 Perth

    Australia

  • 25 Citations
  • 3 h-Index
20142019
If you made any changes in Pure these will be visible here soon.

Research Output 2014 2019

  • 25 Citations
  • 3 h-Index
  • 3 Article
  • 1 Abstract/Meeting Abstract
  • 1 Letter
  • 1 Doctoral Thesis
2019

Optimisation of multiplex immunofluorescence for a non-spectral fluorescence scanning system

Anyaegbu, C. C., Lee-Pullen, T. F., Miller, T. J., Abel, T. N., Platell, C. F. & McCoy, M. J., 1 Sep 2019, In : Journal of Immunological Methods. 472, p. 25-34 10 p.

Research output: Contribution to journalArticle

Fluorescent Antibody Technique
Fluorescence
Color
Immunophenotyping
Paraffin

The Cancer Stem-Like Cell Marker SOX2 is Prognostic and May Predict Response to Chemotherapy in Colon Cancer

Miller, T. J., McCoy, M. J., Anyaegbu, C., Cheah, K., Hemmings, C., Bulsara, M., Iacopetta, B. & Platell, C. F., Nov 2017, In : Asia-Pacific Journal of Clinical Oncology. 13, p. 73-74 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

9 Citations (Scopus)
Open Access
Chemoradiotherapy
Regulatory T-Lymphocytes
Rectal Neoplasms
Cell Count
Neoplasms
2016
405 Downloads (Pure)

The effect of tumour antigen properties on the efficiency of cross-presentation

Anyaegbu, C. C., 2016, (Unpublished)

Research output: ThesisDoctoral Thesis

File
Cross-Priming
Neoplasm Antigens
Nuclear Antigens
Neoplasms
Immunotherapy
2014
12 Citations (Scopus)

Chemotherapy enhances cross-presentation of nuclear tumor antigens

Anyaegbu, C., Lake, R., Heel, K., Robinson, B. & Fisher, S., 22 Sep 2014, In : PLoS One. 9, 9, p. e107894

Research output: Contribution to journalArticle

Open Access
Cross-Priming
Nuclear Antigens
Chemotherapy
Neoplasm Antigens
drug therapy